Literature DB >> 1900539

Human immunodeficiency virus type 1 Tat does not transactivate mature trans-acting responsive region RNA species in the nucleus or cytoplasm of primate cells.

D J Chin1, M J Selby, B M Peterlin.   

Abstract

Human immunodeficiency virus (HIV)-encoded transactivator Tat is essential for viral gene expression and replication. By interacting with a nascent RNA stem-loop called the trans-acting responsive region (TAR). Tat increases rates of initiation and/or elongation of HIV transcription. Several reports have also suggested that Tat has additional effects on mature HIV RNA species including modification of primary transcripts in the nucleus and their increased translation in the cytoplasm. These posttranscriptional effects are most pronounced in the Xenopus oocyte. To investigate directly whether Tat has similar effects on viral transcripts in cells that are permissive for HIV replication, we cotransfected and microinjected human and monkey cells with Tat and TAR in the form of DNA or RNA. Whereas Tat transactivated TAR DNA targets, it did not transactivate TAR RNA targets in the nucleus of microinjected cells or in the cytoplasm of transfected cells. We conclude that in cells permissive for viral replication, Tat exerts its effect primarily at the level of HIV transcription.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900539      PMCID: PMC239982     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.

Authors:  M F Laspia; A P Rice; M B Mathews
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

2.  100-kDa polypeptides in peripheral clathrin-coated vesicles are required for receptor-mediated endocytosis.

Authors:  D J Chin; R M Straubinger; S Acton; I Näthke; F M Brodsky
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 3.  HIV trans-activation and transcription control mechanisms.

Authors:  K A Jones
Journal:  New Biol       Date:  1989-11

4.  Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.

Authors:  M J Selby; E S Bain; P A Luciw; B M Peterlin
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

5.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.

Authors:  M A Muesing; D H Smith; D J Capon
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

6.  A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.

Authors:  S Roy; U Delling; C H Chen; C A Rosen; N Sonenberg
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

7.  The use of Xenopus oocytes for the expression of cloned genes.

Authors:  J B Gurdon; M P Wickens
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism.

Authors:  I Edery; R Petryshyn; N Sonenberg
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

9.  Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA.

Authors:  D N SenGupta; R H Silverman
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

10.  Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation.

Authors:  N T Parkin; E A Cohen; A Darveau; C Rosen; W Haseltine; N Sonenberg
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  7 in total

1.  Variable inhibition of cell-free translation by HIV-1 transcript leader sequences.

Authors:  A P Geballe; M K Gray
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

2.  The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Authors:  Johanie Charbonneau; Karine Gendron; Gerardo Ferbeyre; Léa Brakier-Gingras
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

3.  Transactivation of heterologous promoters by HIV-1 tat.

Authors:  P Han; R Brown; J Barsoum
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

4.  Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences.

Authors:  L A Cupelli; J Lenz
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK.

Authors:  Brian J Krueger; Katayoun Varzavand; Jeffrey J Cooper; David H Price
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

6.  Integrative analyses of conserved WNT clusters and their co-operative behaviour in human breast cancer.

Authors:  Umair Seemab; Sulaman Nawaz; Sajid Rashid
Journal:  Bioinformation       Date:  2011-12-10

7.  Different effects of the TAR structure on HIV-1 and HIV-2 genomic RNA translation.

Authors:  Ricardo Soto-Rifo; Taran Limousin; Paulina S Rubilar; Emiliano P Ricci; Didier Décimo; Olivier Moncorgé; Mary-Anne Trabaud; Patrice André; Andrea Cimarelli; Théophile Ohlmann
Journal:  Nucleic Acids Res       Date:  2011-11-24       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.